잇츠
잇츠한불 Stock: price and insider trades · South Korea
잇츠한불: what insiders have been doing
Only a handful of insider records exist for 잇츠한불, the last one from 17 December 2021, too few to describe a trend. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 837 of 26,911 companies
81.8
score / 100
Value86
Quality78
FCF yld14%
Earn yld8.8%
EV/EBITDA4.6x
ROE9.8%
Gross mgn66%
Net mgn11%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
₩10,750
Analyst consensus
Income statement
Revenue₩153.4B
Gross profit₩101.5B66% margin
EBITDA₩41.8B27% margin
Net income₩16.7B19.4% margin
Valuation
Beta0.43
Balance sheet & cash
Market cap₩189.4B
Total debt₩4.7B
Free Cash Flow₩26.3B
Debt / Equity1%
Profitability & ownership
ROE9.8%
ROA2.8%
% insiders61.6%
% institutions0.6%
Last declaration on 17 December 2021
Declarations2 total
- ●Executives0DART
- ●Executives0DART
2 of 2 declarations
About 잇츠한불
잇츠한불 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the manufacturing and distribution of pharmaceutical and healthcare products.
